Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism α-synuclein inhibitors(Synuclein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | Belgium | 29 Sep 2025 | |
| Parkinson Disease | Preclinical | Denmark | 29 Sep 2025 | |
| Parkinson Disease | Preclinical | Greece | 29 Sep 2025 |





